|
|
Post by itellthefuture777 on Aug 28, 2017 18:31:30 GMT -5
|
|
|
|
Post by mnholdem on Aug 29, 2017 7:22:12 GMT -5
IMO, this piece published by Equities.com is an excellent article that provides potential Wall Street investors with a broader exposure to MannKind Corporation, it's pulmonary deliver technology and pipeline. Highlighting Michael Castagna's background is a plus as well, as it conveys that there is now an experienced pharmaceuticals CEO at the helm.  |
|
|
|
Post by ilovekauai on Aug 29, 2017 10:49:15 GMT -5
Excellent article! You go Michael C! Making it happen for all of us! Mahalo!!!
|
|
|
|
Post by dreamboatcruise on Aug 29, 2017 11:20:14 GMT -5
All of this is very encouraging... because I suspect this is coming about due to a much more proactive leadership. Matt went through a lot with/for MNKD, but I suspect he was a bit burned out by the end.
|
|
